Type 1 leprosy reaction manifesting after discontinuation of adalimumab therapy. | Arch Dermatol;145(3): 349-51, 2009 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Type 1 leprosy reaction manifesting after discontinuation of adalimumab therapy.

Camacho, Ivan D; Valencia, Isabel; Rivas, Maria P; Burdick, Anne E.

Arch Dermatol ; 145(3): 349-51, 2009 Mar.

Article in En | MEDLINE | ID: mdl-19289788

Subject(s)

Antibodies, Monoclonal/therapeutic use; Leprosy, Borderline/diagnosis; Adalimumab; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid/drug therapy; Humans; Leprosy, Borderline/pathology; Male; Middle Aged

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leprosy, Borderline / Antibodies, Monoclonal Limits: Humans / Male / Middle aged Language: En Journal: Arch Dermatol Year: 2009 Document type: Article Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leprosy, Borderline / Antibodies, Monoclonal Limits: Humans / Male / Middle aged Language: En Journal: Arch Dermatol Year: 2009 Document type: Article Country of publication: United States